This article is more than 5 years old. Information may no longer be current.
Top gastroenterology stories: Steroid injection beneficial after esophageal dilation, ulcerative colitis drug shows efficacy
Click Here to Manage Email Alerts
Among the top stories in gastroenterology this week was a study that found that a steroid injection helps prevent strictures after esophageal dilation and phase 2 trial findings that indicated efficacy for an oral ulcerative colitis drug candidate.
Other top stories included research findings revealing that antidepressants and psychological therapies reduce irritable bowel syndrome symptoms, the link between proton pump inhibitor monotherapy and cardiovascular risk was insufficient and blue laser imaging for early gastric cancer was better at detecting the disease than white-light imaging. – by Alaina Tedesco
Steroid injection helps prevent strictures after esophageal dilation
A steroid injection immediately after endoscopic balloon dilation helped patients avoid refractory esophageal strictures, according to research published in the American Journal of Gastroenterology. Read more.
Ulcerative colitis drug shows efficacy in European phase 2 trial
Abivax announced that its oral ulcerative colitis drug candidate met the clinical and endoscopic endpoints of a phase 2a trial. Read more.
Antidepressants, psychological therapies reduce irritable bowel syndrome symptoms
Antidepressants can help reduce symptoms of irritable bowel syndrome by targeting the interaction between the brain and the gut, according to a meta-analysis published in The American Journal of Gastroenterology. Read more.
Insufficient evidence to link proton pump inhibitors to CV risk
Researchers found no solid evidence of an association between proton pump inhibitor monotherapy and increased CV risk, according to a meta-analysis published in Alimentary Pharmacology & Therapeutics. Read more.
Blue laser imaging better at detecting early gastric cancer
The use of blue laser imaging-bright during screening for early gastric cancer was better at detecting the disease than the more commonly used white-light imaging, according to research published in Gastrointestinal Endoscopy. Read more.